Plasma Retinol-Binding Protein 4 (RBP4) Levels and Risk of Coronary Heart Disease | Zendy

Qi Sun | Zendy; Urban A. Kiernan | Zendy; Ling Shi | Zendy; David Phillips | Zendy; Barbara B. Kahn | Zendy; Frank B. Hu | Zendy; JoAnn E. Manson | Zendy; Christine M. Albert | Zendy; Kathryn M. Rexrode | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Plasma Retinol-Binding Protein 4 (RBP4) Levels and Risk of Coronary Heart Disease

Author(s) -

Qi Sun,

Urban A. Kiernan,

Ling Shi,

David Phillips,

Barbara B. Kahn,

Frank B. Hu,

JoAnn E. Manson,

Christine M. Albert,

Kathryn M. Rexrode

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.002073

Subject(s) - medicine , retinol binding protein 4 , coronary heart disease , cardiology , retinol binding protein , retinol , obesity , vitamin , insulin resistance , adipokine

Retinol-binding protein 4 (RBP4) may play an important role in the origin of insulin resistance and metabolic syndrome. Few prospective data are available on the relationship between RBP4 and coronary heart disease (CHD). Furthermore, previous studies did not distinguish among full-length and truncated forms of RBP4 that might have various biological activities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research